(1-4-cyclohexyl-1-trityl-1H-imidazol-2-yl)butan-2-one | 1224735-61-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: (1-4-cyclohexyl-1-trityl-1H-imidazol-2-yl)butan-2-one
• 英文别名: 1-(4-Cyclohexyl-1-tritylimidazol-2-yl)butan-2-one；1-(4-cyclohexyl-1-tritylimidazol-2-yl)butan-2-one
• CAS: 1224735-61-8
• 化学式: C₃₂H₃₄N₂O
• 分子量: 462.635
• InChiKey: VCQZPEIATSPILD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.1
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  34.9
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (1-4-cyclohexyl-1-trityl-1H-imidazol-2-yl)butan-2-one 、 3-氟-4-羟基苯甲醛 、 尿素 在 溶剂黄146 作用下， 反应 16.0h， 生成 、 (4S)-5-(4-cyclohexyl-1H-imidazol-2-yl)-6-ethyl-4-(3-fluoro-4-hydroxy-phenyl)-3,4-dihydro-1H-pyrimidin-2-one
  参考文献：
  名称：

  A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability

  摘要：

  Following the previous SAR of a novel dihydropyrimidinone scaffold as HIV-1 replication inhibitors a detailed study directed towards optimizing the metabolic stability of the ester functional group in the dihydropyrimidinone (DHPM) scaffold is described. Replacement of the ester moiety by thiazole ring significantly improved the metabolic stability while retaining antiviral activity against HIV-1 replication. These novel and potent DHPMs with bioisosteres could serve as advanced leads for further optimization. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.01.133
• 作为产物：
  描述：

  2-溴-1-环己基乙酮 在 正丁基锂 、 三乙胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 生成 (1-4-cyclohexyl-1-trityl-1H-imidazol-2-yl)butan-2-one
  参考文献：
  名称：

  A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability

  摘要：

  Following the previous SAR of a novel dihydropyrimidinone scaffold as HIV-1 replication inhibitors a detailed study directed towards optimizing the metabolic stability of the ester functional group in the dihydropyrimidinone (DHPM) scaffold is described. Replacement of the ester moiety by thiazole ring significantly improved the metabolic stability while retaining antiviral activity against HIV-1 replication. These novel and potent DHPMs with bioisosteres could serve as advanced leads for further optimization. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.01.133

文献信息

• [EN] ANTI VIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
  申请人：PASTEUR INSTITUT KOREA

  公开号：WO2010046780A3

  公开（公告）日：2011-01-13
• A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability
  作者：Junwon Kim、Taedong Ok、Changmin Park、Wonyoung So、Mina Jo、Youngmi Kim、Minjung Seo、Doohyun Lee、Suyeon Jo、Yoonae Ko、Inhee Choi、Youngsam Park、Jaewan Yoon、Moon Kyeong Ju、JiYe Ahn、Junghwan Kim、Sung-Jun Han、Tae-Hee Kim、Jonathan Cechetto、Jiyoun Nam、Michel Liuzzi、Peter Sommer、Zaesung No

  DOI：10.1016/j.bmcl.2012.01.133

  日期：2012.4

  Following the previous SAR of a novel dihydropyrimidinone scaffold as HIV-1 replication inhibitors a detailed study directed towards optimizing the metabolic stability of the ester functional group in the dihydropyrimidinone (DHPM) scaffold is described. Replacement of the ester moiety by thiazole ring significantly improved the metabolic stability while retaining antiviral activity against HIV-1 replication. These novel and potent DHPMs with bioisosteres could serve as advanced leads for further optimization. (C) 2012 Elsevier Ltd. All rights reserved.